Copy number loss of FBXW7 is related to gene expression and poor prognosis in esophageal squamous cell carcinoma

Takehiko Yokobori, Koshi Mimori, Masaaki Iwatsuki, Hideshi Ishii, Fumiaki Tanaka, Tetsuya Sato, Hiroyuki Toh, Tomoya Sudo, Takeshi Iwaya, Yoichi Tanaka, Ichiro Onoyama, Hiroyuki Kuwano, Keiichi I. Nakayama, Masaki Mori

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

FBXW7 is a tumor suppressor gene that plays a role in cell cycle regulation via Myc degradation. However, the clinical significance of FBXW7 in esophageal squamous cell carcinoma (ESCC) has not been evaluated. The purpose of this study was to assess the clinical significance of FBXW7 for prognosis in human ESCC. Real-time RT-PCR was used to examine the expression of FBXW7 to determine its clinicopathological significance in 75 cases of ESCC. Overall survival rate was calculated using the Kaplan-Meier method, while multivariate survival was analyzed with the Cox hazard model. FBXW7 suppression analysis was performed to examine proliferation potency and Myc expression in the FBXW7 siRNA groups. The relationship between FBXW7 expression and the copy number loss of FBXW7 was examined in clinical samples of ESCC. Finally, FBXW7 copy number loss was linked to prognosis in 42 ESCC patients. FBXW7 expression in cancer was lower compared to non-cancer tissues (P=0.003) and is an independent prognostic factor. The proliferation rates and Myc protein expression were significantly enhanced in FBXW7 siRNA cells compared to the controls. Cases with a loss of FBXW7 copy number had low FBXW7 expression and a poorer prognosis than cases with no loss of copy number. Genetic alterations in esophageal cancer lead to the loss of FBXW7 expression and increased cell proliferation. These genetic alterations of FBXW7 status may provide a prognostic factor for ESCC patients.

Original languageEnglish
Pages (from-to)253-259
Number of pages7
JournalInternational journal of oncology
Volume41
Issue number1
DOIs
Publication statusPublished - Jul 1 2012

Fingerprint

Gene Expression
Proportional Hazards Models
Small Interfering RNA
Esophageal Neoplasms
Tumor Suppressor Genes
Esophageal Squamous Cell Carcinoma
Real-Time Polymerase Chain Reaction
Cell Cycle
Survival Rate
Cell Proliferation
Survival
Neoplasms
Proteins

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Copy number loss of FBXW7 is related to gene expression and poor prognosis in esophageal squamous cell carcinoma. / Yokobori, Takehiko; Mimori, Koshi; Iwatsuki, Masaaki; Ishii, Hideshi; Tanaka, Fumiaki; Sato, Tetsuya; Toh, Hiroyuki; Sudo, Tomoya; Iwaya, Takeshi; Tanaka, Yoichi; Onoyama, Ichiro; Kuwano, Hiroyuki; Nakayama, Keiichi I.; Mori, Masaki.

In: International journal of oncology, Vol. 41, No. 1, 01.07.2012, p. 253-259.

Research output: Contribution to journalArticle

Yokobori, Takehiko ; Mimori, Koshi ; Iwatsuki, Masaaki ; Ishii, Hideshi ; Tanaka, Fumiaki ; Sato, Tetsuya ; Toh, Hiroyuki ; Sudo, Tomoya ; Iwaya, Takeshi ; Tanaka, Yoichi ; Onoyama, Ichiro ; Kuwano, Hiroyuki ; Nakayama, Keiichi I. ; Mori, Masaki. / Copy number loss of FBXW7 is related to gene expression and poor prognosis in esophageal squamous cell carcinoma. In: International journal of oncology. 2012 ; Vol. 41, No. 1. pp. 253-259.
@article{2c1c0b40209643edb04e628c7e71d2bb,
title = "Copy number loss of FBXW7 is related to gene expression and poor prognosis in esophageal squamous cell carcinoma",
abstract = "FBXW7 is a tumor suppressor gene that plays a role in cell cycle regulation via Myc degradation. However, the clinical significance of FBXW7 in esophageal squamous cell carcinoma (ESCC) has not been evaluated. The purpose of this study was to assess the clinical significance of FBXW7 for prognosis in human ESCC. Real-time RT-PCR was used to examine the expression of FBXW7 to determine its clinicopathological significance in 75 cases of ESCC. Overall survival rate was calculated using the Kaplan-Meier method, while multivariate survival was analyzed with the Cox hazard model. FBXW7 suppression analysis was performed to examine proliferation potency and Myc expression in the FBXW7 siRNA groups. The relationship between FBXW7 expression and the copy number loss of FBXW7 was examined in clinical samples of ESCC. Finally, FBXW7 copy number loss was linked to prognosis in 42 ESCC patients. FBXW7 expression in cancer was lower compared to non-cancer tissues (P=0.003) and is an independent prognostic factor. The proliferation rates and Myc protein expression were significantly enhanced in FBXW7 siRNA cells compared to the controls. Cases with a loss of FBXW7 copy number had low FBXW7 expression and a poorer prognosis than cases with no loss of copy number. Genetic alterations in esophageal cancer lead to the loss of FBXW7 expression and increased cell proliferation. These genetic alterations of FBXW7 status may provide a prognostic factor for ESCC patients.",
author = "Takehiko Yokobori and Koshi Mimori and Masaaki Iwatsuki and Hideshi Ishii and Fumiaki Tanaka and Tetsuya Sato and Hiroyuki Toh and Tomoya Sudo and Takeshi Iwaya and Yoichi Tanaka and Ichiro Onoyama and Hiroyuki Kuwano and Nakayama, {Keiichi I.} and Masaki Mori",
year = "2012",
month = "7",
day = "1",
doi = "10.3892/ijo.2012.1436",
language = "English",
volume = "41",
pages = "253--259",
journal = "International Journal of Oncology",
issn = "1019-6439",
publisher = "Spandidos Publications",
number = "1",

}

TY - JOUR

T1 - Copy number loss of FBXW7 is related to gene expression and poor prognosis in esophageal squamous cell carcinoma

AU - Yokobori, Takehiko

AU - Mimori, Koshi

AU - Iwatsuki, Masaaki

AU - Ishii, Hideshi

AU - Tanaka, Fumiaki

AU - Sato, Tetsuya

AU - Toh, Hiroyuki

AU - Sudo, Tomoya

AU - Iwaya, Takeshi

AU - Tanaka, Yoichi

AU - Onoyama, Ichiro

AU - Kuwano, Hiroyuki

AU - Nakayama, Keiichi I.

AU - Mori, Masaki

PY - 2012/7/1

Y1 - 2012/7/1

N2 - FBXW7 is a tumor suppressor gene that plays a role in cell cycle regulation via Myc degradation. However, the clinical significance of FBXW7 in esophageal squamous cell carcinoma (ESCC) has not been evaluated. The purpose of this study was to assess the clinical significance of FBXW7 for prognosis in human ESCC. Real-time RT-PCR was used to examine the expression of FBXW7 to determine its clinicopathological significance in 75 cases of ESCC. Overall survival rate was calculated using the Kaplan-Meier method, while multivariate survival was analyzed with the Cox hazard model. FBXW7 suppression analysis was performed to examine proliferation potency and Myc expression in the FBXW7 siRNA groups. The relationship between FBXW7 expression and the copy number loss of FBXW7 was examined in clinical samples of ESCC. Finally, FBXW7 copy number loss was linked to prognosis in 42 ESCC patients. FBXW7 expression in cancer was lower compared to non-cancer tissues (P=0.003) and is an independent prognostic factor. The proliferation rates and Myc protein expression were significantly enhanced in FBXW7 siRNA cells compared to the controls. Cases with a loss of FBXW7 copy number had low FBXW7 expression and a poorer prognosis than cases with no loss of copy number. Genetic alterations in esophageal cancer lead to the loss of FBXW7 expression and increased cell proliferation. These genetic alterations of FBXW7 status may provide a prognostic factor for ESCC patients.

AB - FBXW7 is a tumor suppressor gene that plays a role in cell cycle regulation via Myc degradation. However, the clinical significance of FBXW7 in esophageal squamous cell carcinoma (ESCC) has not been evaluated. The purpose of this study was to assess the clinical significance of FBXW7 for prognosis in human ESCC. Real-time RT-PCR was used to examine the expression of FBXW7 to determine its clinicopathological significance in 75 cases of ESCC. Overall survival rate was calculated using the Kaplan-Meier method, while multivariate survival was analyzed with the Cox hazard model. FBXW7 suppression analysis was performed to examine proliferation potency and Myc expression in the FBXW7 siRNA groups. The relationship between FBXW7 expression and the copy number loss of FBXW7 was examined in clinical samples of ESCC. Finally, FBXW7 copy number loss was linked to prognosis in 42 ESCC patients. FBXW7 expression in cancer was lower compared to non-cancer tissues (P=0.003) and is an independent prognostic factor. The proliferation rates and Myc protein expression were significantly enhanced in FBXW7 siRNA cells compared to the controls. Cases with a loss of FBXW7 copy number had low FBXW7 expression and a poorer prognosis than cases with no loss of copy number. Genetic alterations in esophageal cancer lead to the loss of FBXW7 expression and increased cell proliferation. These genetic alterations of FBXW7 status may provide a prognostic factor for ESCC patients.

UR - http://www.scopus.com/inward/record.url?scp=84862835658&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862835658&partnerID=8YFLogxK

U2 - 10.3892/ijo.2012.1436

DO - 10.3892/ijo.2012.1436

M3 - Article

C2 - 22576686

AN - SCOPUS:84862835658

VL - 41

SP - 253

EP - 259

JO - International Journal of Oncology

JF - International Journal of Oncology

SN - 1019-6439

IS - 1

ER -